Aktivolabs scores US$10 million capital commitment from Mitsui to fuel global expansion
![Aktivolabs scores US$10 million capital commitment from Mitsui to fuel global expansion](https://media.asiaone.com/sites/default/files/styles/article_main_image/public/original_images/Dec2022/Aktivo.jpg?itok=JASYAQDy)
The issuer is solely responsible for the content of this announcement.
Aktivolabs is a digital health-science company founded in 2017. It provides accessible, affordable, evidence-based, and individualised digital health solutions that help populations understand and manage their risk of chronic diseases. The platform harnesses real-time digital health data elements in a low-touch, cost-effective manner with measurable actuarial and actionable value to life and health insurers. It functions as a real-time action decision engine to drive hyper-personalised financial and insurance product development, generates pay-as-you-live insurance products and provides deeper customer experience tailored to client engagement through its proprietary experiential technology.
Aktivolabs currently operates in Singapore, Hong Kong, India, Japan, Australia, Philippines, Taiwan, Malaysia, Indonesia, Vietnam, Thailand, Macau and the UAE and is growing worldwide.
To learn more, please visit the website www.aktivolabs.com .
Mitsui & Co., Ltd. (8031: JP) is a global trading and investment company with a diversified business portfolio that spans approximately 63 countries and regions in Asia, Europe, North, Central & South America, The Middle East, Africa and Oceania.
Leveraging its strengths, Mitsui has further diversified beyond its core profit pillars to create multifaceted value in new areas, including innovative Energy Solutions, Healthcare & Nutrition and through a strategic focus on high-growth Asian markets. This strategy aims to derive growth opportunities by harnessing some of the world’s main mega-trends: sustainability, health & wellness, digitalization and the growing power of the consumer.
Mitsui has a long heritage in Asia, where it has established a diverse and strategic portfolio of businesses and partners that gives it a strong differentiating edge, provides exceptional access for all global partners to the world’s fastest-growing region and strengthens its international portfolio. For more information, please visit https://www.mitsui.com/ .
About SEEDS
As the investment arm of Enterprise Singapore, SEEDS Capital catalyzes smart monies into Singapore-based early-stage technology startups. We co-invest with institutional investors in innovative startups with strong intellectual content and global market potential. We focus on nascent and strategic industries such as Advanced Manufacturing & Engineering, Health & Biomedical Sciences and Urban Solutions & Sustainability and other emerging technologies such as Agri-tech, Artificial Intelligence, Blockchain, Quantum Computing and Space Technologies. Post-investment, we leverage Enterprise Singapore’s networks across industries and global overseas centers to support the growth of our portfolio companies. Today, we have over 100 startups in our portfolio and we work with more than 40 co-investment partners. For more information, please visit https://www.enterprisesg.gov.sg
About Adaptive Capital Partners
Adaptive Evergreen fund invests in innovative and disruptive technology startups with a primary focus on healthcare technology, consumer tech and fintech. Adaptive is on a mission to support exceptional companies and founders in their entrepreneurial journey, and the solid growth of the startups ecosystem in Singapore and Asia Pacific (“APAC”). We believe that venture capital is not just about numbers. It is about how well you understand the startups and create value for them. We are here as enablers to support entrepreneurs in their exceptional journey.